Results 1 to 10 of about 1,759,660 (235)
Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases [PDF]
Clinics, 2015 OBJECTIVES: Fibrolamellar hepatocellular carcinoma is a rare primary malignant liver tumor that differs from conventional hepatocellular carcinoma in several aspects.
Aline Lopes Chagas +10 more
doaj +9 more sources
Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features [PDF]
Clinics, 2016 OBJECTIVE To investigate immunohistochemical markers of angiogenesis and their association with pathological prognostic features in hepatocellular carcinoma and cirrhotic liver.
Osmar Damasceno Ribeiro +2 more
doaj +4 more sources
Autophagy-related long non-coding RNA MIR210HG plays a therapeutic role in hepatocellular carcinoma [PDF]
Discover OncologyObjective This study aimed to investigate the role of the autophagy-related long noncoding RNA (lncRNA) MIR210HG in hepatocellular carcinoma and its potential as a therapeutic target.
Chaoqun Zhang +6 more
doaj +2 more sources
Hepatocellular carcinoma [PDF]
Nature Reviews Disease Primers, 2021 Liver cancer remains a global health challenge, with an estimated incidence of >1 million cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cancer and accounts for ~90% of cases. Infection by hepatitis B virus and hepatitis C virus are the main risk factors for HCC development, although non-alcoholic steatohepatitis ...
Llovet, Josep M. +9 more
openaire +4 more sources
Hepatocellular carcinoma [PDF]
Nature Reviews Disease Primers, 2016 Liver cancer is the second leading cause of cancer-related deaths globally and has an incidence of approximately 850,000 new cases per year. Hepatocellular carcinoma (HCC) represents approximately 90% of all cases of primary liver cancer. The main risk factors for developing HCC are well known and include hepatitis B and C virus infection, alcohol ...
Llovet, Josep M. +6 more
+9 more sources
Hepatocellular carcinoma [PDF]
British Journal of Cancer, 2001 The number of papers published regarding hepatocellular carcinoma between 1999 and 2001 increased from previous years. This year a study confirmed the increase in incidence in the United States. Also, several studies established for the first time that tobacco smoking was a risk factor for the development of this tumor. Several studies established that
Giovannini, M +4 more
openaire +4 more sources
Journal of Translational Medicine, 2023 Background Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide because of rapid progression and high incidence of metastasis or recurrence.
Chuanzheng Wang +7 more
doaj +1 more source
Resveratrol protects against chronic alcohol-induced liver disease in a rat model
STEMedicine, 2022 Hepatic ethanol metabolism participates in the pathogenesis of alcoholic liver disease (ALD). We aimed to evaluate the protecting effects and underlying mechanisms of Resveratrol against ALD.
Hanzhang Zhu +3 more
doaj +1 more source
A case of hepatocellular carcinoma recurring during pregnancy [PDF]
, 2021 The hepatocellular carcinoma is more common in African and Asian countries with an incidence in women at around 5.5/10,000. Hepatocellular carcinoma is an aggressive tumour, with high recurrence rates, reaching around 50%.
Chatbi, Zaineb +4 more
core +2 more sources
Heat shock protein HSPA13 promotes hepatocellular carcinoma progression by stabilizing TANK
Cell Death Discovery, 2023 HSPA13, an important member of the heat shock protein family, plays an essential role in the oncogenesis of many organs, but the mechanism and function in hepatocellular carcinoma (HCC) is still unclear.
Xuesong Cen +9 more
doaj +1 more source